Status:
COMPLETED
A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis
Lead Sponsor:
Pfizer
Conditions:
Bronchitis, Chronic
Eligibility:
All Genders
36-74 years
Phase:
PHASE3
Brief Summary
This study compared the clinical efficacy and safety of azithromycin with that of amoxicillin-clavulanic acid, in patients between the ages of 35 and 75 years, presenting with an exacerbation of chron...
Eligibility Criteria
Inclusion
- Outpatients presenting with an exacerbation of chronic bronchitis including: chronic bronchitis with obstructive respiratory disorders documented by a forced expiratory volume of below 80% and higher than 35% of the theoretical value, within the previous 12 months; and thought to be of infectious origin
Exclusion
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2003
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00649831
Start Date
October 1 2002
End Date
June 1 2003
Last Update
October 21 2008
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Anzin, France, 59410
2
Pfizer Investigational Site
Avignon, France, 84 000
3
Pfizer Investigational Site
Avignon, France, 84000
4
Pfizer Investigational Site
Dijon, France, 21000